Press Release – For immediate release – 5:45PM CET
- MediScan® commercial development will initially focus on China and Europe.
- Median will strengthen, re-engage and scale its Key Opinion Leader networks for its Patient Care Business line globally.
Median Technologies, The Imaging Phenomics Company® announces today that it is expanding its Patient Care business with the release of MediScan® for the automated detection, quantification and monitoring of suspicious lesions diagnosed in CT scans. Median Technologies intends to leverage Mediscan® for strengthening the commercial development and market penetration of its application portfolio in Asia and more specifically in China. Median also plans to focus on the commercial development of Mediscan® in Europe by leveraging its legacy hospital-based radiology customers, who were early adopters of its predecessor, LMS (Lesion Management Solution) product.
The recent opening of Median’s operations in Hong Kong, Tokyo and Shanghai, as well as the skyrocketing development of Median’s Boston-based subsidiary, will strengthen, re-engage and scale the KOL networks of the company for the Patient Care business lines, worldwide. Median intends to continue to closely collaborate with FURUI, its Chinese investor and partner, to help develop KOL networks and to develop medical partnerships with major hospital and cancer centers. The goal is to position MediScan® as the reference medical device for major programs dedicated to cancer screening, detection, diagnosis and monitoring in China.
Future releases of MediScan® include the integration of new technology based on the latest advances in artificial intelligence, could computing and Big Data analytics.
“MediScan® is a critical part of Median’s commitment to improving care for patients worldwide. We believe that MediScan® fills a huge unmet need in helping governments and healthcare systems to efficiently and accurately screen, detect, help diagnose, and monitor patients at risk for and those living with cancer. It underscores, Median’s core value of helping patients in need,” said Jeanne Hecht, COO of Median Technologies.
MediScan® is a registered trademark of Median Technologies.